UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	August 28, 2024

Accession Number:	0001193125-24-207752
Submission Type:	POS AM
CIK: 0001538210 Company Name: NexImmune, Inc. File Number: 333-263399